Position in NVS
as of Jun 30, 2026
· filed Jul 2, 2026
Position Value
$1,688,031
+$119,289 QoQ
Shares Held
10,771
+4.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
#141
of 649 holders
Holding Since
Sep 2021
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Versant Capital Management, Inc holds $22,172,877 across 17 Drug Manufacturers - General names. NVS ranks #5 (7.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,562 | $4,272,370 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
73,361 | $4,227,060 | |
| 3 | JNJ |
Johnson & Johnson
|
13,834 | $3,513,420 | |
| 4 | ABBV |
AbbVie Inc.
|
6,899 | $1,736,064 | |
| 5 | NVS |
Novartis AG
This page
|
10,771 | $1,688,031 | |
| 6 | MRK |
Merck & Co., Inc.
|
12,085 | $1,552,922 | |
| 7 | AZN |
Astrazeneca PLC
|
7,263 | $1,377,210 | |
| 8 | AMGN |
Amgen Inc
|
1,980 | $716,997 |
All Filings in NVS
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,688,031 | 10,771 | Shares | Sole | 2026-07-02 | |
| 2026-03-31 | $1,568,742 | 10,270 | Shares | Sole | 2026-04-07 | |
| 2025-12-31 | $1,173,825 | 8,514 | Shares | Sole | 2026-01-08 | |
| 2025-09-30 | $985,652 | 7,686 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $933,350 | 7,713 | Shares | Sole | 2025-07-07 | |
| 2025-03-31 | $836,880 | 7,507 | Shares | Sole | 2025-04-03 | |
| 2024-12-31 | $76,388 | 785 | Shares | Sole | 2025-01-03 | |
| 2024-09-30 | $10,236 | 89 | Shares | Sole | 2024-10-07 | |
| 2024-06-30 | $1,596 | 15 | Shares | Sole | 2024-07-08 | |
| 2024-03-31 | $1,450 | 15 | Shares | Sole | 2024-04-03 | |
| 2023-12-31 | $44,426 | 440 | Shares | Sole | 2024-01-08 | |
| 2023-09-30 | $44,818 | 440 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $44,400 | 440 | Shares | Sole | 2023-07-10 | |
| 2023-03-31 | $40,480 | 440 | Shares | Sole | 2023-04-10 | |
| 2022-12-31 | $1,360 | 15 | Shares | Sole | 2023-01-25 | |
| 2022-09-30 | $1,140 | 15 | Shares | Sole | 2022-12-30 | |
| 2021-09-30 | $736 | 9 | Shares | Sole | 2021-10-29 | |
| No filing history on record for this holder in this stock. | ||||||